• OPEN AN ACCOUNT
Indian Indices
Sensex
82,626.76 -1,048.16
( -1.25%)
Global Indices
Nasdaq
49,514.94 41.95
(0.08%)
Dow Jones
6,856.39 2.63
(0.04%)
Hang Seng
57,040.53 -599.31
(-1.04%)
Nikkei 225
10,448.94 46.50
(0.45%)
Forex
USD-INR
90.59 -0.07
(-0.07%)
EUR-INR
107.56 -0.26
(-0.24%)
GBP-INR
123.48 -0.32
(-0.26%)
JPY-INR
0.59 0.00
(0.20%)

EQUITY - MARKET SCREENER

Sangani Hospitals Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
79231
INE0OVI01010
26.1926517
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANGANI
23.99
62.13
EPS(TTM)
Face Value()
Div & Yield %
1.88
10
0
 

utique enterprises limited
Hyundai Motor India Q3 PAT rises 6% YoY to Rs 1,234 crore
Feb 02,2026
Total revenue from operations grew 7.96% year-on-year (YoY) to Rs 17,973.49 crore during the quarter.

Profit before tax in Q3 FY26 stood at Rs 1,666.03 crore, up 6.61% from Rs 1,562.73 crore recorded in Q3 FY25.

During the quarter, EBITDA rose 7.61% YoY to Rs 2,018.30 crore from Rs 1,875.50 crore in Q3 FY25, while the EBITDA margin declined marginally to 11.2% from 11.3% in the year-ago quarter.

On a nine-month basis, the company reported a 3.72% increase in consolidated net profit to Rs 4,175.89 crore in 9M FY26, compared with Rs 4,025.86 crore in 9M FY25. Revenue from operations rose 1.16% YoY to Rs 51,847.18 crore in 9M FY26.

Tarun Garg, managing director & chief executive officer, said, “The third-quarter performance underscores our resilience and strong execution of “Quality of Growth” strategy, marked by healthy growth in volumes, revenue and profitability. Notably on a year-to-date basis, EBITDA margins expanded to 12.8% as against 12.5% last year, supported by our efforts towards improving sales mix and prudent cost control measures. As we move ahead, the robust January’26 sales number gives us great momentum towards a healthy 2026.”

Hyundai Motor India manufactures and sells passenger cars, along with vehicle parts and accessories.

The counter rose 0.60% to settle at Rs 2,196.50 on the BSE.